The ABDA's efforts aim to affect change, actively work on proposals to protect and improve key policies at local, state and federal levels and ultimately improve patient outcomes and quality of life. Addressing issues such as access to care, treatment innovations, research and healthcare policies, the voice of those affected by Behcet's Disease and rare diseases is of utmost importance.

Behcet's Awareness Month

May is Behcet's Awareness Month and May 20 is International Behcet's Awareness Day. Check out our calendar of activities under "Events" at the top of this page. 

Join us on May 14, 2022 8-9 pm EST for the "Let's Talk Mental Health" virtual event. Please email ABDAparty@behcets.com to receive and automated reply with a link to join the event. 

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for booster shots of the Pfizer-BioNTech COVID-19 vaccine. Certain populations are now eligible to receive a booster shot of the Pfizer-BioNTech vaccine at least 6 months after receiving the second Pfizer-BioNTech shot. These populations include people ages 65 years and older, people ages 18 years and older who have underlying medical conditions, and people ages 18 years and older who live or work in high-risk settings.